Literature DB >> 19922137

The importance of the SMN genes in the genetics of sporadic ALS.

Philippe Corcia1, William Camu, Julien Praline, Paul H Gordon, Patrick Vourch, Christian Andres.   

Abstract

The human genome contains two SMN (survival motor neuron) genes: SMN1, the telomeric gene whose homozygous deletion causes spinal muscular atrophy (SMA), and SMN2, the centromeric version whose copy number modulates the phenotype of SMA. We performed a Medline search and reviewed all of the publications that focus on SMN1 and SMN2 in amyotrophic lateral sclerosis (ALS) to analyse whether these genes also act as risk factors or phenotypic modulators in ALS. While homozygous deletion of SMN1 was not associated in ALS, abnormal SMN1 copy numbers significantly increased the risk of ALS. The role of the SMN2 gene in ALS needs further clarification. The existence of abnormal SMN1 copy numbers in ALS provides additional evidence that gene copy number variants may contribute to neurodegeneration and might open new approaches to treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922137     DOI: 10.3109/17482960902759162

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  17 in total

Review 1.  Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments.

Authors:  Luc Dupuis; Andoni Echaniz-Laguna
Journal:  Curr Drug Targets       Date:  2010-10       Impact factor: 3.465

Review 2.  Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions.

Authors:  Julia K Nussbacher; Ricardos Tabet; Gene W Yeo; Clotilde Lagier-Tourenne
Journal:  Neuron       Date:  2019-04-17       Impact factor: 17.173

3.  SMN1 gene duplications are associated with sporadic ALS.

Authors:  H M Blauw; C P Barnes; P W J van Vught; W van Rheenen; M Verheul; E Cuppen; J H Veldink; L H van den Berg
Journal:  Neurology       Date:  2012-02-08       Impact factor: 9.910

Review 4.  Genetics of motor neuron disorders: new insights into pathogenic mechanisms.

Authors:  Patrick A Dion; Hussein Daoud; Guy A Rouleau
Journal:  Nat Rev Genet       Date:  2009-10-13       Impact factor: 53.242

5.  Nanomolar naloxone attenuates neurotoxicity induced by oxidative stress and survival motor neuron protein deficiency.

Authors:  Ya-Yun Hsu; Yuh-Jyh Jong; Yu-Ting Lin; Yu-Ting Tseng; Shih-Hsien Hsu; Yi-Ching Lo
Journal:  Neurotox Res       Date:  2013-07-27       Impact factor: 3.911

6.  A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy.

Authors:  Natalia N Singh; Maria Shishimorova; Lu Cheng Cao; Laxman Gangwani; Ravindra N Singh
Journal:  RNA Biol       Date:  2009-07-14       Impact factor: 4.652

Review 7.  Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder.

Authors:  Chi-Tso Chiu; Zhifei Wang; Joshua G Hunsberger; De-Maw Chuang
Journal:  Pharmacol Rev       Date:  2013-01-08       Impact factor: 25.468

8.  The neuroprotective drug riluzole acts via small conductance Ca2+-activated K+ channels to ameliorate defects in spinal muscular atrophy models.

Authors:  Maria Dimitriadi; Min Jeong Kye; Geetika Kalloo; Jill M Yersak; Mustafa Sahin; Anne C Hart
Journal:  J Neurosci       Date:  2013-04-10       Impact factor: 6.167

9.  Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of Survival motor neuron 1.

Authors:  Babykumari P Chitramuthu; David C Baranowski; Denis G Kay; Andrew Bateman; Hugh Pj Bennett
Journal:  Mol Neurodegener       Date:  2010-10-14       Impact factor: 14.195

Review 10.  The Role of immune and inflammatory mechanisms in ALS.

Authors:  P A McCombe; R D Henderson
Journal:  Curr Mol Med       Date:  2011-04       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.